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Background: Haemophilus influenzae is a significant cause of childhood otitis media, and also has an absolute
growth requirement for heme. Recent microarray studies using three H. influenzae isolates were used to propose a
putative core of genes responsive to iron and heme levels. Included in the core modulon were thirty seven genes
that are preferentially expressed under iron/heme limitation, most of which are directly involved with iron and or
heme acquisition. In this report, the core iron/heme modulon was further refined following microarray analysis of
two additional nontypeable H. influenzae isolates from patients with otitis media. The transcriptional status of the
genes comprising the refined iron/heme core modulon was then assessed in vivo, in a chinchilla model of otitis
media. These in vivo experiments were performed to address the hypothesis that iron and heme regulated genes
are both highly expressed in vivo and important, during clinical infection.
Results: Microarray analysis of two additional H. influenzae strains resulted in the definition of a core of iron/heme
responsive genes. This core consisted of 35 genes maximally expressed under heme restriction and a further 20
genes maximally expressed in heme replete conditions. In vivo studies were performed with two nontypeable H.
influenzae strains, 86-028NP and HI1722. The majority of operons identified as members of the core modulon by
microarray were also actively upregulated in the chinchilla ear during otitis media. In 86-028NP, 70% of the operons
were significantly upregulated while in HI1722 100% of the operons were upregulated in samples recovered from
the chinchilla middle ear.
Conclusion: This study elucidates a conserved core of H. influenzae genes the transcription of which is altered by
the availability of iron and heme in the growth environment, and further assesses transcription of these genes
in vivo. Elucidation of this modulon allows for identification of genes with unrecognized roles in iron/heme
acquisition or homeostasis and/or potential roles in virulence. Defining these core genes is also of potential
importance in identifying targets for therapeutic and vaccine designs since products of these genes are likely to be
preferentially expressed during growth in iron/heme restricted sites of the human body.
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The human body has evolved multiple mechanisms to
provide nutritional immunity including those involved in
sequestration of extracellular iron and heme. Bacterial
pathogens have co-evolved multiple mechanisms to over-
come these defenses and to utilize the sequestered micro-
nutrients. Haemophilus influenzae is a human-specific* Correspondence: pwhitby@ouhsc.edu
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reproduction in any medium, provided the orpathogen that commonly resides as a commensal of the
nasopharyngeal cavity. H. influenzae can ascend the eusta-
chian tube and cause otitis media (OM) in children, can
spread to cause disease in the lungs of patients with
COPD and cystic fibrosis, and also can cause invasive
disease [1-3]. These multiple environments inhabited by
H. influenzae are all likely to be iron and heme (FeHm)
restricted and are likely to differ in the iron and/or heme
sources available to colonizing or invading bacteria. To
overcome this FeHm restriction and utilize the multipli-
city of possible FeHm sources, H. influenzae has evolved aLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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or heme-containing proteins as sources of these essential
micronutrients [4-9].
H. influenzae has an absolute growth requirement for
heme. The requirement is specifically for the immediate
heme precursor, protoporphyrin IX (PPIX), since most
strains possess the enzyme ferrochelatase [10]. In the
human host, there is essentially no free PPIX, and the
potential sources of heme are intracellular, in the form of
hemoglobin or heme-containing enzymes such as the
cytochromes, that are unavailable to invading microorgan-
isms [11-13]. Hemoglobin released by lysis of erythrocytes
is avidly bound by the serum protein haptoglobin, and the
hemoglobin-haptoglobin complex is rapidly cleared from
the circulation by hepatocytes [11,14]. Free heme, princi-
pally derived from the breakdown of methemoglobin, is
bound by either of the serum proteins hemopexin or albu-
min and cleared from the circulatory system by hepatocytes
[11,13]. Utilization of hemoglobin, the hemoglobin-hapto-
globin complex, heme-hemopexin and heme-albumin com-
plexes by H. influenzae requires a functional tonB gene
indicating that uptake of heme from these host sources is
mediated by TonB-dependent outer membrane proteins
(TD-OMPs) [15-17]. An additional source of iron is serum
ferri-transferrin, the utilization of which is mediated by the
TD-OMP TbpA [18,19]. Previous studies have character-
ized both the potential human sources of iron and heme,
including transferrin, hemoglobin, hemoglobin-haptoglo-
bin, and the heme-hemopexin and heme-albumin com-
plexes [4-6], as well as many of the OMPs mediating their
utilization. These include the hemoglobin/hemoglobin-
haptoglobin-binding TD-OMPs (Hgps) [20-22], theheme-
utilization TD-OMP (Hup) [23], and the heme-hemopexin
TD-OMP (Hxu) are regulated by the environmental avail-
ability of FeHm, and are preferentially transcribed under
FeHm-restricted growth conditions [24,25].
Previously, we characterized the transcriptional changes
that occur upon transition from a FeHm-starved to a
FeHm-replete environment in three unrelated fully se-
quenced H. influenzae isolates, the extensively passaged
laboratory strain Rd KW20, the type b H. influenaze (Hib)
strain 10810 and the invasive non-typeable (NTHi) strain
R2866 [24,25]. These data established that Rd KW20 had
162 genes responding whereas the two clinical isolates
had significantly more such genes (respectively strains
10810 and R2866 had 351 and 363 genes). Transcription
of 74 genes was altered by FeHm levels in all three strains.
In addition, each isolate had several genes whose regula-
tion was unique to that isolate. Rd KW20 had 15 genes
that were upregulated by FeHm restriction that were
present, but not regulated, in the other isolates. Strain
10810 had 78 and R2866 had 35 such genes. Each isolate
also had a subset of genes that were both distinct to that
isolate and responsive to FeHm levels. Rd KW20 had asingle unique gene upregulated during FeHm restricted
growth. In contrast, 10810 had 39 and R2866 had 12 simi-
larly unique and regulated genes [25]. Overall, strains
10810 and R2866 more closely resembled one another in
their transcriptional profiles than either resembled strains
Rd KW20. Taken together, these data demonstrate that
substantial heterogeneity exists among the individual
FeHm-responsive modulons of these H. influenzae iso-
lates. Nevertheless, these studies allowed us to define a
core modulon of FeHm-responsive genes, numbering 74,
that were responsive to alterations in FeHm levels in all
three studied H. influenzae isolates.
The current study had two specific goals: 1) to further
evaluate the FeHm-core regulon of H. influenzae by
characterizing the in vitro transcriptomes of two add-
itional NTHI strains, 86-028NP and R2866 which were
isolated from the nasopharynx and the middle ear, re-
spectively, of children with OM.; 2) to assess whether
the regulation of gene transcription by FeHm levels
in vitro accurately reflects the transcriptional status of
the same genes in vivo in an animal model of acute OM.
Results
Defining the FeHm window of NTHi 86-028NP and R2846
for microarray analysis
Previously the growth conditions required to establish the
FeHm-responsive genes of three H. influenzae strains were
carefully defined [24,25]. In these previous studies the
growth parameters included preincubation of the primary
inoculum in growth medium containing heme at a con-
centration of 0.1 μg/ml prior to inoculation of the experi-
mental culture. Initially the same growth protocol was
used in the transcriptional analysis of isolates 86-028NP
and R2846 reported herein. Under these conditions both
isolates lost viability during the experimental growth
period and the RNA yields from each were significantly
decreased compared to the previous isolates studied. In
previous experiments the H. influenzae isolates Rd KW20,
R2866 and 10810 showed a continuous growth over
the period of the experiment [24,25]. In contrast, NTHi
86-028NP showed a similar growth profile to approxi-
mately 90 minutes, with peak CFU values of 4 x107 (+/−
9.2 x106) but displayed a subsequent decrease thereafter
to 2.8 X 107 (+/− 3.5x 106) CFU at 150 minutes. Isolate
R2846 showed a similar profile to 86-028NP. RNA sam-
ples at 90 and 110 minutes from various experimental rep-
licates showed varying yields of both total RNA and
specific target mRNA, which resulted in a failure of the
Q-PCR to analyze the potentially FeHm regulated genes.
Thus, a systematic approach was taken to determine opti-
mal conditions for analysis of in vitro gene transcription
of these isolates. It seemed possible loss of viability of the
isolates resulted from a deficiency of heme in the primary
inoculum. As a result, a range of heme concentrations in
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culture was incubated at 2 μg/ml heme, both isolates
retained viability across the period of the experiment and
consistent transcriptional data was obtained. Using a set
of test genes that included hitA, tbp1, hxuC and ompP2,
we found that the kinetics of FeHm-mediated transcrip-
tional regulation were similar to those observed for the
three previously studied H. influenzae strains (data not
shown).Table 1 Q-PCR validation of Microarray Results
Fold Changea
R2846 86-028NP
Locusb Microarray Q-PCR Microarray Q-PCR
HI0075 −2.3 −6.4 −1.7 −2.8
HI0095 −2.2 −14.4 −3.5 −4.4
HI0097 −2.4 −68.0 −2.4 −4.0
HI0153 −2.0 −2.5 −1.5 −2.1
HI0185 12.2 2.3 2.9 6.5
HI0253 −1.6 −11.3 −1.8 −3.2
HI0994 −8.4 −7.6 −3.2 −5.2
HI1094 1.6 3.0 1.7 1.9
HI1369 −8.0 −10.0 −1.7 −8.3
HI1384 1.6 2.3 2.0 26.3
aFold change in transcript levels between FeHm replete and
deplete conditions.
bGene locus in Rd KW20.Microarray analysis of isolates NTHi 86-028NP and R2846
A microarray chip was designed that contained all the
coding regions of the NTHi isolates 86-028NP and
R2846. The same chip had been previously utilized to
study the FeHm modulons of the Hib strain 10810 and
the NTHi strain R2866 [25]. Triplicate cultures of each
isolate were prepared and sampled as previously de-
scribed [25].
Approximately 50–60 μg total RNA was purified from
each experimental sample and submitted to NimbleGen
Inc., where the samples underwent in-house quality con-
trol prior to microarray analysis. Of the 1820 ORFs on
the array corresponding to NTHi 86-028NP genes, 64
(3.5%) were differentially transcribed in a statistically sig-
nificant manner (Additional file 1: Fold transcriptional
change of 86-028NP genes following supplementation of
FeHM-restricted media with exogenous FeHm). Of these
64 genes, 39 (61%) were preferentially transcribed in
FeHm-restricted conditions and 25 (39%) were max-
imally transcribed in FeHm-replete conditions. Of the
1664 ORFS represented on the array that correspond to
NTHi R2846 genes, 94 (5.6%) were significantly differen-
tially transcribed. Of these 94 genes, 70 (74%) were max-
imally transcribed in FeHm-restricted conditions and 24
(26%) in FeHm-replete conditions (Additional file 2:
Fold transcriptional change of R2846 genes following
supplementation of FeHM-restricted media with exogen-
ous FeHm). In both sets of microarray data, transcripts of
the known FeHm-repressible genes tbp1, hitA and hxuC
were elevated under FeHm restriction while transcripts of
the constitutive gene ompP2 showed no significant
changes in either isolate. These findings were in accord-
ance with the preliminary quantitative PCR (Q-PCR)
experiments. [For simplicity, genes preferentially tran-
scribed in FeHm-restricted media or FeHm-replete media
will now be referred to as FeHm negative (FeHm-ve) or
FeHm positive (FeHm+ ve) respectively]. In comparison
with the previous microarray studies, the number of genes
responding to altered FeHm status is lower in both 86-
028NP and R2846 than was observed for the previously
reported isolates. This discrepancy may reflect the result-
ing effect of the additional heme required in the initial
growth of the inocula cultures for these isolates.Validation of the microarray data
Several genes were selected for analysis by Q-PCR to val-
idate the microarray data. A separate experiment was per-
formed for each isolate to purify RNA from FeHm-deplete
and -replete cells using the same conditions as those de-
scribed for the microarray analysis. Genes analyzed for
each isolate included ten examples of genes preferentially
expressed under FeHm limitation or supplementation. We
observed concordance of 100% between the Q-PCR and
the microarray transcription data (Table 1).
Comparison of the microarray data of H. influenzae
isolates 86-028NP, R2846, R2866, Rd KW20 and 10810
In an initial analysis of the FeHm-responsive genes of
H. influenzae, the well-characterized laboratory strain
Rd KW20 had 80 FeHm-ve genes and 82 FeHm + ve
genes [24]. Addition of data from the Hib isolate 10810
and the NTHi isolate R2866, subsequently established a
common core of 37 FeHm-ve and 37 FeHm + ve genes
responding to FeHm availability in these 3 strains [25].
Combining that data with the newly acquired data from
R2846 and 86-028NP now allows the further refinement
of the definition of the core FeHm modulon for the spe-
cies H. influenzae. We now define a gene as a member
of this modulon if it is significantly regulated in at least
4 of the 5 isolates evaluated. In a few operons, one or
two genes distal to the promoter may have fallen below
the 1.5-fold inclusion limit but were included as part of
the core if they were regulated in at least 3 isolates. The
core FeHm modulon of the 5 isolates contains 35 genes
that are preferentially transcribed under FeHm-deplete
conditions and 20 genes that are preferentially tran-
scribed under FeHm-replete conditions (Tables 2 and
3). Of the FeHm-ve genes the majority (20 genes; 57%)
have a known or putative role in iron and/or heme
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hemopexin uptake system (hxuABC), the transferrin up-
take system (tbp12), the energy transducing TonBExb-
BExbD system and the inner membrane iron transporterTable 2 Loci preferentially expressed in 4 or more strains in F
Locusa Descriptionb
HI0035 Conserved hypothetical protein/predicted transporter
HI0075 Anaerobic ribonucleoside-triphosphate reductase, alpha subun
HI0095 Putative methyltransferase
HI0097 Iron (III) ABC transporter, periplasmic binding protein HitA
HI0098 Iron (III) ABC transporter, permease protein HitB
HI0099 Iron (III) ABC transporter, ATP-binding protein HitC
HI0113 Probable TonB-dependent heme receptor HemR
HI0153 Putative anaerobic C4-dicarboxylate transporter
HI0251 Protein TonB
HI0252 Biopolymer transport ExbD
HI0253 Biopolymer transport protein ExbB
HI0262 Heme-hemopexin utilization protein HxuC
HI0263 Heme-hemopexin utilization protein HxuB
HI0264 Heme-hemopexin utilization protein HxuA
HI0359 Fe/Mn/Zn ABC transporter, permease protein YfeD
HI0360 Fe/Mn/Zn ABC transporter, permease protein YfeC
HI0361 Fe/Mn/Zn ABC transporter, ATP-binding protein YfeB
HI0362 Fe/Mn/Zn ABC transporter, periplasmic binding protein YfeA
HI0534 Aspartate-ammonia lyase AspA
HI0584 Putative peptidase/hydrolase
HI0661 Hemoglobin-haptoglobin binding protein HgpB
HI0691 Glycerol kinase GlpK
HI0712 Hemoglobin-haptoglobin binding protein HgpC
HI0809 Phosphoenolpyruvate carboxykinase PckA
HI0994 Transferrin-binding protein Tbp1
HI0995 Transferrin-binding protein Tbp2
HI0997m Putative outer membrane protein OmpU
HI1210 Malate dehydrogenase Mdh
HI1356 4-alpha-glucanotransferase (amylomaltase) MalQ
HI1357 1,4-alpha-gulcan branching enzyme GlgB
HI1358 Glycogen debranching enzyme GlgX
HI1359 Glucose-1-phosphate adenyltransferase GlgC
HI1360 Glycogen synthase GlgA
HI1369 Probable TonB-dependent transporter
HI1427 Putative ABC transport, periplasmic binding protein
aGene locus in Rd KW20.
bName and description of the gene based upon annotation of Rd KW20 or R2846 a
cFold change as determined from the microarray data. Numbers in italics are below
threshold. Numbers in bold are above the 1.5 fold threshold but have a p-value abo
1.5-fold threshold.
dlocus not included on the Rd KW20 array but expression determined to be aboveHitABC were significantly upregulated in all five isolates.
Several genes whose products are predicted to be directly
involved in uptake of heme across the OM were also regu-
lated in all strains. These include a probable heme uptakeeHm-restricted conditions
Fold changec
R2866 10810 Rd R2846 86-028NP
−2.46 −1.74 −1.55 −2.16 −1.19
it NrdD −2.95 −2.54 −4.03 −2.34 −1.66
−12.56 −3.93 −10.21 −2.15 −3.47
−14.27 −4.52 −8.15 −2.39 −2.38
−1.80 −2.70 −3.55 −2.33 −2.24
−2.01 −2.16 −3.56 −2.19 −2.03
−4.72 −2.28 −2.36 −3.39 −1.64
−2.70 −2.24 not ond −2.00 −1.54
−1.99 −1.69 −2.75 −1.42 −1.40
−2.45 −1.87 −3.02 −1.54 −1.76
−3.07 −2.26 −2.69 −1.64 −1.84
−24.69 −4.03 −10.30 −3.95 −2.64
−29.31 −3.29 −9.20 −2.92 −3.93
−18.55 −2.86 −7.44 −2.55 −2.11
−2.92 ns −4.35 −1.31 −1.66
−3.54 ns −6.90 −1.34 −1.81
−7.89 ns −8.91 −1.74 −2.12
−6.01 −1.17 −11.74 −1.57 −1.78
−1.56 −3.38 −3.12 −2.62 −1.67
−1.84 −1.59 −1.69 −1.75 ns
−6.52 −4.14 −1.20 −2.51 −3.09
−5.71 −3.40 −1.61 −1.58 ns
−9.82 −2.94 −6.64 −2.02 ns
−6.41 −3.16 −2.87 −1.92 −1.35
−9.56 −8.16 −12.40 −8.43 −3.15
−19.45 −16.53 −13.94 −8.57 −6.92
−15.68 −14.61 not ond −9.24 −7.44
−5.29 −2.68 −2.47 −1.97 −1.49
−2.32 −2.25 −1.82 −2.29 −1.76
−2.75 −2.67 −1.59 −2.44 −1.65
−2.38 −2.80 −1.51 −2.35 −1.48
−3.28 −3.10 −1.73 −2.32 −1.44
−2.03 −2.56 −1.52 −2.03 ns
−10.65 −1.56 −7.02 −8.04 −1.70
−6.60 −2.32 −6.12 −2.65 −1.52
nd R2866.
the 1.5 fold threshold but have a p-value below the statistically significant
ve the statistically significant threshold. ns = non significant and below
2 fold change in expression by Q-PCR.
Table 3 Loci preferentially expressed in 4 or more strains in FeHm-replete conditions
Fold changec
Locusa Descriptionb R2866 10810 Rd R2846 86-028NP
HI0006m Formate dehydrogenase-N, alpha subunit FdnG +7.58 +8.36 not ond +1.44 +1.71
HI0007 Formate dehydrogenase-N, Fe-S beta subunit FdnH +7.49 +6.00 +3.40 +1.21 +1.73
HI0008 Formate dehydrogenase-N, cytochrome B556 gamma subunit, FdnI +7.47 +5.23 +3.20 ns +1.76
HI0009 Formate dehydrogenase-N, accessory protein FdnE +3.35 +3.43 +1.88 ns +1.75
HI0185 Formaldehyde dehydrogenase, glutathione-dependent AdhC +5.86 +4.01 +8.04 +12.18 +2.85
HI0343 Twin-arginine signal-peptide-binding chaperone NapD +3.19 ns +1.66 +1.78 +1.60
HI0344 Periplasmic nitrate reductase subunit NapA +2.67 ns not ond +1.79 +1.62
HI0345 Periplasmic nitrate reductase, ferredoxin-type protein NapG +4.47 ns +1.88 +2.13 +1.91
HI0346 Periplasmic nitrate reductase, ferredoxin-type protein NapH +3.37 +1.25 +1.93 +1.86 +1.71
HI0347 Periplasmic nitrate reductase, electron transfer subunit NapB +4.77 ns +1.90 +1.68 +2.17
HI0348 Periplasmic nitrate reductase, cytochrome C-type subunit NapC +3.20 ns +1.71 +1.69 +2.34
HI0980 DNA architectural protein Fis +4.67 +2.56 +2.06 +1.66 +1.15
HI1066 Nitrite reductase complex, transmembrane protein NrfD +6.34 +2.24 +1.88 +3.84 ns
HI1067 Nitrite reductase complex, Fe-S subunit NrfC +6.99 +1.70 +1.52 +2.98 +3.53
HI1068 Nitrite reductase complex, periplasmic cytochrome subunit NrfB +9.49 ns +2.00 +4.75 +3.81
HI1069 Nitrite reductase complex, periplasmic cytochrome C552 subunit NrfA +8.33 +2.53 +2.13 +5.11 +3.65
HI1078 Probable amino acid ABC transporter, ATP-binding protein +1.88 +1.89 +1.52 +2.21 +1.16
HI1094 Cytochrome c-type biogenesis protein CcmF +2.53 +1.60 +1.81 +1.63 +1.65
HI1384 Ferritin protein A1 +3.21 +2.01 +2.60 +1.62 +2.06
HI1385 Ferritin protein A2 +4.13 +2.24 +2.94 +1.58 +2.23
aGene locus in Rd KW20.
bName and description of the gene based upon annotation of Rd KW20, R2846 and R2866.
c Fold change as determined from the microarray data. Numbers in italics are below the 1.5 fold threshold but have a p-value below the statistically significant
threshold. Numbers in bold are above the 1.5 fold threshold but have a p-value above the statistically significant threshold. ns = non significant and below
1.5-fold threshold.
dlocus not included on the Rd KW20 array but expression determined to be above 2 fold change in expression by Q-PCR.
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OMP designated HI1369 in Rd KW20, and OmpU
(HI0997m in Rd KW20). Several other FeHm-related
genes were also found to be regulated in four isolates.
These include genes encoding the hemoglobin-haptoglobin
receptors HgpB and HgpC and the putative inner mem-
brane divalent cation transporter system YfeABCD.
Among the 20 core genes preferentially expressed under
FeHm-replete conditions, only six were regulated in all 5
isolates. These include genes encoding the ferritin sub-
units (HI1384-HI1385) as well as a glutathione-dependent
formaldehyde dehydrogense (HI0185), two components of
the nitrate reduction complex (HI1067 and HI1069), and
a cytochrome C biogenesis gene (HI1094).
Comparison of the 5 genome core, with the previously
described 3 genome core
A previous iteration of the FeHm-responsive core modu-
lon of H. influenzae was based on microarray analyses of
3 isolates [25]. For the FeHm-ve gene set inclusion of
the two additional strains reported herein resulted in the
exclusion of 17 genes included in the previous 3-genomebased core modulon and the addition of 14 genes that
were previously excluded. None of the 17 genes that
were removed from the FeHm-ve core are believed to be
directly involved in FeHm acquisition. However, addi-
tions to the consensus FeHm-ve core include many
genes with an established or putative role in FeHm
homeostasis. One locus added to the FeHm-ve core as a
result of the current study is the the yfeABCD locus
(HI0361-HI0364 in Rd KW20). This locus was previously
excluded since it is constitutively expressed in the Hib
strain 10810, possibly as a result of a nucleotide substitu-
tion within a putative Fur box upstream of the gene [26].
The inclusion of the yfeABCD locus in the modified core
reported herein attests to the value of multi-genome ana-
lysis for the definition of regulons within a species. Other
genes added to the core included some within operons in
which the first gene was previously reported as part of the
3-genome core.
An even greater degree of change was seen for the set of
genes preferentially expressed under FeHm-replete condi-
tions. Twenty five genes that were part of the 3-genome
core were excluded from the 5-genome core while eight
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of the locus encoding components of the nitrate reductase
complex, napDAGHBC (HI0343-HI0348 in Rd KW20).
Another added gene was the promoter proximal gene of
the fdnGHIE (HI0006m-HI0009 in Rd KW20) operon
which encodes a nitrate-inducible formate dehydrogenase.
This gene had been excluded from the previous Rd KW20
array although it was subsequently shown by Q-PCR to be
regulated in that isolate. The last added gene was within
the nfrABCD (HI1066-HI1069 in Rd KW20) operon, the
other genes of which were already included in the core.
These three operons include 14 of 20 genes (70%) in-
cluded in the final FeHm+ ve core.
There were 47 genes in 32 putative operons that did
not exhibit significant changes in transcription in either
R2846 or 86-028NP but were regulated by FeHm in the
previous studies with Rd KW20, 10810 and R2866 [25].
Given the additional heme required to maintain viability
in strains R2846 and 86-028NP, these genes may repre-
sent loci whose expression is only altered under extreme
FeHm stress. Examination of these genes revealed no
clear pattern of expression beyond a suggestion that the
lower FeHm levels have more profoundly stressed the
cells. Genes that are preferentially expressed in FeHm
deplete conditions in the three original isolates include
those that encode a protein that replaces an oxidatively-
damaged pyruvate lyase subunit, several transporters
and associated utilization proteins (predicted tricarboxy-
late, gluconate, tryptophan and uracil transporters), a
periplasmic NAD nucleotidase involved in NAD and
NAD(P) scavenging, a stationary phase translation in-
hibitor and a tRNA recycling protein, the Dps protein
that protects DNA from oxidative damage, and several
other enzymes. Among genes preferentially expressed
following the return to FeHm-replete conditions, 12 of
the 27 are genes whose products are involved in tRNA
or ribosome maturation. This suggests that protein syn-
thesis may have been suppressed during FeHm stress.
The remaining genes have only putative assigned
functions.
In vitro examination of the FeHm core modulon in the
clinical NTHi isolate HI1722
We were unable to utilize strain R2846 for in vivo stud-
ies since in preliminary experiments in the chinchilla in-
fected animals rapidly developed symptoms of inner ear
infection which represent criteria for termination of the
protocol. As a result an alternate strain was selected for
in vivo determination of transcription. The NTHi isolate
HI1722 was chosen for these studies because it was iso-
lated from a patient with OM and has been previously
utilized in the chinchilla model of OM [27]. To facilitate
the in vivo examination, this isolate was partially genome
sequenced to determine the presence or absence of coreFeHm-responsive genes and the sequence of individual
genes to ensure homology of the Q-PCR primers. Simi-
larly to the NTHi strains 86-028NP and R2846, strain
HI1722 required preincubation with 2 μg/ml heme to
prevent cell death over the time course of the regulation
studies (data not shown). Initially the transcriptional re-
sponse of the genes tbp1, hxuC, and ompP2 were exam-
ined. Similar kinetics of expression were observed for
each gene as those previously described for the five
other isolates previously examined (data not shown).
The transcriptional profiles of the genes comprising
the 5-genome FeHm-responsive core were examined in
HI1722 by Q-PCR. For genes in operons, a single gene
was chosen as representative of the operon. Of the 28
operons in the FeHm core 18 were regulated in this pre-
viously unstudied isolate including every operon that
was FeHm responsive in all 5 previously studied isolates
(Table 4). In addition, 7 genes unresponsive to FeHm
levels in any of the previously studied strains were se-
lected as control genes and the transcript levels deter-
mined for HI1722. Transcript levels of all 7 control
genes did not change in response to FeHm levels in
HI1722 (data not shown).
Transcriptional status of the core modulon of 86-028-NP
and HI1722 during experimental OM in the chinchilla
A major goal of this study was to determine the in vivo
transcriptional status of the core FeHm-modulon genes
in the chinchilla middle ear a clinically relevant animal
model of disease. To allow a direct comparison of tran-
script levels between the in vivo and in vitro derived
samples, each was normalized to the time zero FeHm
supplemented in vitro grown culture of the respective
isolate. In this way the expression level determined by
Q-PCR of the ear samples can be compared to the
in vitro FeHm deplete/supplemented values since they
are all normalized to the same internal “housekeeping”
gene gyrA. In essence, the in vitro data provide two indi-
ces of transcriptional status, an upper level, correspond-
ing to upregulation and a lower level corresponding to
fully FeHm repressed basal transcription. For each gene
in the FeHm core, the fold change in transcripts in re-
sponse to FeHm addition in vitro had been determined
(Tables 2, 3 and 4). Since a fully repressed sample is used
as a normalizer, all the other values are “fold change
with respect to full repression” thus positive numbers
above 1.5 indicate increased transcription, values be-
tween +/− 1.5 are not considered indicative of a change
and values below −1.5 are further repressed. To test the
hypothesis that genes in the FeHm core are transcribed
in vivo, cohorts of chinchillas were infected and ear effu-
sion samples were collected at various times for deter-
mination of the transcriptional status of genes in the
FeHm core modulon. Following Q-PCR of each gene of
Table 4 Transcription of core FeHm-responsive genes in
the NTHi isolates 86-028NP and HI1722
Fold Changeb
86-028NP HI1722
Locusa Gene In vitro In vivoc in vitro in vivod
HI0035 2.25 15.53 1.07 29.37
HI0075 nrdD 2.4 3.81 5.28 21.31
HI0095 9.69 7.11 29.61 22.01
HI0097 hitA 19.92 2.38 66.15 34.66
HI0113 hemR 1.68 2.47 3.02 5.82
HI0153 dcuB 1.96 7.17 1.39 5.57
HI0253 exbB 3.11 −2.44 9.02 37.74
HI0263 hxuB 5.97 5.95 11.91 14.19
HI0362 yfeA 3.14 2.17 19.93 81.46
HI0534 aspA 5.19 6.74 −1.06 36.7
HI0584 1.75 2.52 1.03 10.05
HI0661 hgpB 11.36 3.01 25.6 129.37
HI0691 glpK 1.39 1.22 −1.11 4.26
HI0809 pckA 2.48 1.3 1.51 29.87
HI0994 tbp1 8.73 3.65 15.66 28.3
HI0997m ompU1 12.68 42.36 7.77 30.71
HI1210 mdh 2.11 2.58 1.21 3.5
HI1356 malQ 2.36 10.27 −1.92 10.86
HI1369 8.94 30.26 5.15 30.63
HI1427 3.63 8.8 3.33 7.42
HI0007 fdnH −2.3 1.15 −3.84 1.81
HI0185 adhC −4.48 −1.42 −5.35 −1.42
HI0343 napD −1.38 1.56 1.00 12.4
HI0980 fis −1.05 1.26 −1.18 2.36
HI1069 nrfA −5.08 2.28 −5.06 9.69
HI1078 tcyC −1.92 2.58 −1.01 3.79
HI1094 ccmF −1.51 9.74 −2.01 4.68
HI1384 ftnA −4.27 −7.88 −6.89 −5.41
aGene locus in Rd KW20.
bFold difference in gene expression levels in theFeHm-deplete in vitro sample
when normalized to replete condition. Numbers in bold are data points that
differ in fold change from that predicted by the core FeHm regulon.
cGeometric mean of 18 samples, normalized to heme-replete in vitro sample.
dGeometric mean of 6 samples, normalized to heme-replete in vitro sample.
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for each gene was determined and compared to the
in vitro data. Table 4 displays the Q-PCR results (geo-
metric mean) for each gene in each isolate together with
the data of the in vitro grown samples (normalized to
heme-replete conditions). Individual data points for each
gene, for each day are shown in Additional file 3: Q-PCR
values for FeHm core genes in 86-028NP infected chin-
chilla ears and in Additional file 4: Q-PCR values for
FeHm core genes in HI1722 infected chinchilla ears. For
most genes, the in vivo level of transcripts was similarto, or in excess of, the in vitro data for FeHm-restricted
conditions. Values are bolded where the transcripts of
a gene showed either a fold change below our cut off
(indicating non regulation) of a fold change opposite to
that predicted by the in vitro FeHm regulon. In addition,
the transcriptional status of the selected genes appears
to be relatively stable across the duration of the experi-
ment (Additional files 3 and 4), indicating that over the
course of the experiment the middle ear fluids remained
FeHm restricted. Several interesting observations were
noted when the in vivo and in vitro data for the two iso-
lates were compared. For genes observed to be preferen-
tially expressed in FeHm-deplete conditions in the
microarray studies, nearly all were expressed at a high
level in vivo. However, many of the operons that were
preferentially expressed in FeHm-replete conditions
were also expressed at a higher level in the in vivo sam-
ples for both isolates. The only exceptions were the
adhC and ftnA genes. A likely explanation for this is that
the microenvironment may contain additional physio-
logical signals such as nutrient depletion, redox stress
and other such stimuli which may lead to expression of
these genes in this environ. A second interesting obser-
vation is the low expression levels of exbB in the 86-
028NP in vivo data (Table 4). This finding was con-
firmed by determination of the transcript levels of tonB
in each of the 86-028NP ear samples. The results were
consistent with the lower expression of exbB in the chin-
chilla ear (data not shown). For the HI1722 isolate, each
of the core FeHm-ve modulon genes were significantly
upregulated in the in vivo samples. Taken in its entirety,
the data discussed in this section confirm that the chin-
chilla ear fluids remain FeHm-limited during the period
of the experimental infection.
Discussion
The two main goals of this study were to refine the core
of FeHm-modulated genes for the species H. influenzae
and assess the correlation of transcriptional profiles ob-
served during experimental OM. In performing the
in vitro studies it was clear that not all H. influenzae iso-
lates are equally resistant to prolonged FeHm starvation.
In previous studies using the three strains Rd KW20,
10810 and R2866, incubation of the seed culture with
0.1 μg/ml heme was sufficient to allow subsequent sur-
vival in FeHm-deplete media for at least a further two
hours and reproducible gene transcript levels over time.
However, for the three strains used in the present study
(86-028NP, R2846 and HI1722) similar conditions led to
rapid loss of viability of the isolates and poor reproduci-
bility of transcript analyses. Titration of the heme in the
preincubation period demonstrated that a minimum of
2 μg/ml heme was required to retain viability of these
strains. The physiological reason for this phenomenon is
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herein share a similar genetic trait distinct from the iso-
lates in the first study. In each of the isolates there is the
insertion of a FeHm-modulated hemoglobin-haptoglobin
binding protein gene (hgpA) at a locus containing the
polyamine genes, potE and speF, which replaces the lat-
ter two genes. In Rd KW20, 10810 and R2866 the potE
and speF genes are also FeHm regulated. Thus, the lack
of potE and speF may be responsible for the reported in-
ability to survive protracted FeHm starvation. It is pos-
sible that the role of the polyamines in potE/speF
containing strains is to provide a protective effect during
fermentative growth as polyamines have been shown to
protect against acid stress [28]. It has been previously
shown that H. influenzae is able to grow fermentatively
with the production of acids as a byproduct [29,30]. In
the isolates lacking these genes, the ability to persist
under fermentative growth would be limited. Thus, a
higher initial concentration of heme may be required to
provide a sufficient intra-cellular concentration to en-
sure adequate functional respiratory enzymes and allow
respiration over the period of the experiment. Further
studies are planned to investigate the role of the poly-
amine locus in long term resistance to FeHm starvation.
Although hgpA and potE/speF share the same genetic lo-
cation and both are maximally expressed under FeHm-
depleted conditions, they have distinct upstream regions
and are not regulated by the same promoter element
(data not shown).
The individual in vitro FeHm modulons indicate that
86-028NP and R2846 are more similar to each other
than they are to any of the three isolates characterized in
our previous studies [24,25]. This may simply result
from the need for additional heme required in the
current studies. In the newly described modulons there
are fewer regulated genes. This is most pronounced in
the subset of genes preferentially expressed under
FeHm-replete conditions. The majority of the differentially
regulated genes appear to be involved in basic metabolism
and include various transferases and ribosome-associated
proteins. While these genes are regulated in Rd KW20,
R2866 and 10810, the lack of regulation in R2846 and
86-028NP indicates a difference in the basic metabolism
between these two sets of isolates. Specifically it suggests
that the higher level of heme leads to less of an impact on
central metabolism during FeHm depletion. Thus, the
current study may more accurately reflect the genes directly
regulated by FeHm availability as opposed to those for
which the transcriptional status is secondary to the conse-
quences of FeHm starvation.
Additionally the current study tested the hypothesis
that genes preferentially expressed under conditions of
FeHm starvation would be similarly upregulated in the
middle ear during experimental infection. Two isolatesthat have been previously used in the chinchilla model
were selected for these studies. In NTHi strain HI1722,
each core gene that was upregulated in FeHm-deplete
conditions in vitro was also apparently upregulated dur-
ing experimental otitis media (Table 4). Combined with
the observation that nearly all of the FeHm-ve genes in
86-028NP were also highly transcribed in vivo, these
findings validate the hypothesis that H. influenzae genes
preferentially transcribed under FeHm-limited growth
are also transcribed in the middle ear during OM.
Conclusions
The targeted examination of gene regulation in the chin-
chilla ear reported herein does not address all of the
FeHm-regulated genes that may contribute to virulence
in that environment for any specific isolate. Rather the
study focused on the core FeHm-responsive genes; the
microarray studies clearly show that each of the isolates
contained additional genes that respond to FeHm stress
in vitro that did not fulfill criteria for inclusion as core
modulon members. It is likely that such non-core
FeHm-responsive genes will also be upregulated in vivo,
and it is likely that more than just core genes are re-
quired for survival in the chinchilla ear. The core FeHm
modulon contains 35 genes preferentially transcribed
under FeHm-deplete conditions and 20 genes preferen-
tially transcribed under FeHm-replete conditions. How-
ever, the total number of FeHm-regulated genes in all 5
studied isolates is approximately 250. It is likely that the
pool of non-core genes allow adaptation to changing
hosts and environmental niches within the host. It is
known that H. influenzae is naturally transformable and
shares genes between co-localized isolates. This is the
fundamental principle of the Distributed Genome Hy-
pothesis [31] and may in part explain why there is a
large degree of heterogeneity of regulation seen between
isolates in vitro, as well as variation in the genomic pres-
ence of various genes that are regulated in individual
isolates. Future studies will focus on identification of all
genes preferentially expressed in vivo with a view to
obtaining a better understanding of the in vivo systems
biology of H. influenzae disease.
Methods
Bacterial strains and growth conditions
NTHi strain 86-028NP is a nasopharyngeal isolate from a
patient who underwent tympanostomy and tube insertion
for chronic OM [32]. NTHi strain R2846 (originally desig-
nated strain 12) was isolated from the middle ear of a child
with acute OM [33]. NTHi strain HI1722 (originally desig-
nated 1728MEE) was isolated from the middle ear of a child
undergoing tympanostomy tube placement for chronic OM
with effusion [27]. Isolates of H. influenzae were routinely
maintained on chocolate agar with bacitracin at 37°C or
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MI) supplemented with 10 μg/ml heme and 10 μg/ml β-
NAD (supplemented BHI; sBHI). Heme-deplete growth was
performed in BHI broth supplemented with 10 μg/ml β-
NAD alone (heme-deplete BHI; hdBHI). Iron and heme re-
stricted media (FeHm deplete) was hdBHI with deferox-
amine (150 μM)
Growth conditions for iron/heme regulated gene
expression
Hemin was purchased from Sigma Chemical Co. (St.
Louis, MO) and used to make stock heme solutions as
previously described [34]. Growth conditions pertaining
to the FeHm-regulation window of H. influenzae strains
Rd KW20, 10810 and R2866 have been defined previ-
ously [24], and were used as the basis to define growth
of NTHi strains R2846 and 86-028NP. For both experi-
mental strains, various conditions were systematically
evaluated to optimize growth characteristics, mainten-
ance of viability consequent to FeHm starvation and re-
producible regulation of gene expression. The following
conditions were found to be optimal for the in vitro ana-
lysis of the regulation of gene transcription by iron and
heme in strains 86-028NP and R2846. To prepare the
primary inocula, H. influenzae were grown in 15 ml con-
ical tubes containing 5 ml of BHI broth supplemented
with 10 μg/ml β-NAD (BHI-NAD) and additionally sup-
plemented with 2 μg/ml heme. These broth cultures
were grown at 37°C on a rotator for 2 hours and were
moderately turbid. To prepare the inocula, cells were
pelleted by centrifugation, washed once in phosphate
buffered saline (PBS) containing 0.1% gelatin and the
pelleted cells were re-suspended in the same buffer. The
suspension was adjusted to an A605nm = 0.50 and diluted
serially in the same buffer to provide an inoculum giving
a final concentration of ~2 x 107 cfu/ml when 5 ml of
inoculum was added to 120 ml FeHm deplete BHI broth.
Broth cultures for analysis of FeHm-mediated regulation
of gene expression were incubated in a rotary shaker at
175 rpm at 37ºC, and 50 μl samples were removed at
30 minute intervals for determination of viable counts.
For Q-PCR analyses, aliquots of 500 μl were removed at
specified times and immediately mixed with 1 ml RNA-
Protect (Qiagen, Valencia, CA) and frozen at −70°C for
later RNA preparation. Sixty milliliter samples for
microarray studies were taken at 90 and 110 minutes of
incubation, immediately mixed with 60 ml RNAProtect
and stored frozen at −70°C for later RNA purification.
RNA purification
Samples for Q-PCR obtained as described above were
thawed, remixed by brief vortexing and incubated at room
temperature for 5 minutes prior to purification using the
RNeasy mini kit (Qiagen). Following purification, thesample was eluted with 40 μl of sterile RNase free water.
Residual chromosomal DNA was removed by digestion
with amplification grade DNase I (Invitrogen, Carlsbad,
CA). The RNA samples were used to prepare cDNA as
previously described [35]. Each 20 μl reaction contained
7 μl template RNA, 5.5 mM MgCl2, 500 μM each dNTP
(dATP, dCTP, dGTP, dTTP), 1 x RT buffer, 80 mU RNase
Inhibitor and 25 U MultiScribe Reverse Transcriptase
(Applied Biosystems, Foster City, CA). The synthesis reac-
tion was incubated at 25°C for 10 minutes followed by a
further 30 minutes at 48°C. The reaction was terminated
by heating at 95°C for 5 minutes. Prior to analysis, the
cDNA was diluted by addition of 180 μl RNase-free water.
Samples for microarray obtained as described above
were thawed and the cells collected by centrifugation.
Total RNA was isolated using Trizol (Invitrogen) as de-
scribed by the manufacturer. Residual genomic DNA
was removed by treatment with RNase-free DNase (Invi-
trogen) as directed by the manufacturer and confirmed
by Q-PCR analysis. The RNA samples were then sub-
jected to LiCl precipitation as previously described [36]
and concentrations determined using a Smartspec3000
(BioRad, Hercules, CA). Finally, to ensure that the RNA
was not degraded, samples were resolved by PAGE using
precast 6% TBE-urea gels (Invitrogen). On receipt by
Nimblegen, each sample was subjected to additional
quality control prior to processing for microarray
analysis.
Samples from in vivo studies were prepared similarly
to those for microarray. However, an additional step was
added to the Trizol extraction. Fifty microliter samples
of chinchilla effusions in RNA Protect (1:1) were added
to 1 ml of Trizol. Prior to isopropanol precipitation, the
top aqueous layer from the Trizol-chloroform extraction
was subjected to a further phenol-chloroform-isoamyl
alcohol, pH 6.6 (25:24:1) extraction to remove contami-
nants that were found to interfere with downstream en-
zymatic reactions.
Quantitative real-time PCR
Q-PCR was performed as previously described [35].
Gene-specific oligonucleotide primers were designed
using Primer Express 2.0 (Applied Biosystems) and syn-
thesized by Operon Technologies (Huntsville, AL) and
were tested to determine amplification specificity, effi-
ciency and for linearity of the amplification with RNA
concentration. Primers are listed in Additional file 5:
Oligonucleotide primers used in this study. A typical
10 μl reaction contained 5 μl of SYBR Green Master
Mix, 250 nM of each primer, and 2.5 μl of cDNA sam-
ple. Quantification reactions for the target transcripts at
each timepoint were performed in quadruplicate and
normalized to concurrently analyzed gyrA mRNA levels
from the same sample. Relative quantification of gene
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Livak and Schmittgen where ΔΔCt = (Ct, gene −Ct, 16s)
time * − (Ct, gene −Ct, 16s) control. [37].
Microarray design
A microarray chip containing probes to all the genes of
the NTHi isolates R2846, 86-028NP and R2866 as well
as the Hib isolate 10810 was designed. The efficacy of
this chip was demonstrated in a previous study [25].
Due to the frequency of phase variation in H. influenzae
and the possibility of sequencing errors, all frame-shifted
open reading frames were included on the arrays as a
complete gene. Oligonucleotide probe sets for the array
were designed by Nimblegen Systems, Inc. (Madison,
WI). Each ORF of each genome is represented by thir-
teen longmer expression probes (60 nucleotides each).
The probes were screened for uniqueness to minimize
cross-hybridization. Each probe was replicated three times
on each chip to increase accuracy.
Arrays were manufactured by Nimblegen Systems, Inc.
by maskless array synthesis using a digital micro-mirror
array-mediated, parallel synthesis process incorporating
5′-photoprotected phosphoramidites as previously de-
scribed [38].
Post scan, the array features within the image file were
extracted using NimbleScan v2.1. This program allows
the user to combine the microarray image with the cor-
responding NimbleGen microarray design file, and op-
tionally, with a gene description file to further map the
image. The resulting alignment can be visually manipu-
lated for further analysis. The Expression Data was proc-
essed using tools available through the Bioconductor
project (www.bioconductor.org). Data was normalized
using quantile normalization [39], and gene calls gener-
ated using the Robust Multichip Average (RMA) algo-
rithm as described [40].
Microarray data analysis
Technical array replicates (three duplicate probe sets
were incorporated into each slide) were averaged prior
to analysis of the three repeat experimental replicates of
each isolate. The data were initially log2 transformed
and compared between FeHm-replete and -deplete con-
ditions by performing individual t tests using the TMEV
software (www.tm4.org) [41]. Genes with a ≥1.5-fold ex-
pression change and P < 0.05 were considered signifi-
cantly altered in gene expression.
Genome sequencing of NTHi strain HI1722
The partial genome sequence of the NTHi strain
HI1722 was obtained using the Applied Biosystems
SOLiD V3.0 platform. A 10 μg sample of chromosomal
DNA was sonicated with the Covaris S2 in order to gen-
erate fragments of 80–110 bp to be used for buildingfragment DNA libraries per existing SOLiD protocols
(Foster City, CA). After shearing, DNA was end repaired
and purified using PureLink PCR purification columns
(Invitrogen) per manufacturer’s protocols. SOLiD se-
quencing adapters (P1 and P2) were ligated to the DNA
fragments and the samples were run on agarose gels in
order to size select and gel purify the 150–200 bp prod-
ucts followed by PCR amplification and nick translation
for the adapter ligated products. Each DNA fragment li-
brary was column purified (Qiagen min-elute columns)
and quantified using the Invitrogen Qubit fluorometer
and broad range DNA assay. A standard amount of
60 pg for each library was used for separate emulsion
PCR reactions (ePCR) following existing SOLiD proto-
cols. Approximately 2.5 ×107 beads were deposited for
each sample onto a separate region of an octet slide for
sequencing. Using the SOLiD V3.0, 50 bp sequencing
reads were generated for each sample and resulting high
quality reads were compared/aligned to the existing gen-
ome sequences of the H. influenzae strains Rd KW20,
86-028NP and 10810 to determine sequence homology
using the SETS software tool that is integrated into the
SOLiD platform. Additional reference alignments and/or
assembly of orphan reads were processed using the CLC
Genomics Workbench (CLC Bio USA, Cambridge, MA)
software package and default parameters for de novo
assembly.Chinchilla model of otitis media
A total of 7 adult chinchillas (Chinchilla laniger) with
no evidence of middle ear infection by either otoscopy
or tympanometry at the beginning of the study were
used. Animals were rested for at least 7 days upon ar-
rival to acclimate them to the vivarium. After acclima-
tion, chinchillas were challenged with H. influenzae in
two separate experiments. Animal procedures have been
described in detail elsewhere [42-44].
In the first experiment five chinchillas were challenged
in both ears transbullarly with approximately 2,000 CFU
of NTHi strain 86-028NP. Transbullar inocula were de-
livered in 300 μl 0.1% gelatin in PBS by direct injection
of bacterial suspensions into the superior bullae. The ac-
tual challenge dose was confirmed by plate count. On
days 4, 7, 10, 14 and 17 post challenge middle ear effu-
sions (MEE) were collected by epitympanic tap (i.e. with-
drawl of fluids from the middle ear cavity using a 1.5
inch 25-gauge hypodermic needle) [44]. The majority of
each recovered MEE was immediately mixed with an
equal volume of RNAProtect and frozen in order to pre-
serve the RNA profile for analysis by Q-PCR. A portion
of each recovered MEE was reserved for determination
of bacterial count using the track dilution method as
previously described [45].
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lenged in both ears transbullarly with approximately
2,000 CFU of NTHi strain HI1722. Epitympanic taps
were attempted on days 4, 7, 11, 14 and 18, after NTHI
challenge. Recovered MEE were treated as described
above.
This study was performed in strict accordance with
the recommendations in the Guide for the Care and Use
of Laboratory Animals (National Institutes of Health).
Animal protocols were reviewed and approved by the
Institutional Animal Care and Use Committee of the
University of Oklahoma Health Sciences Center.
Accession number
The microarray data from this study has been deposited
with the Gene Expression Omnibus. The accession num-
ber is GSE38649.
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